A retrospective analysis of the impact of azithromycin maintenance therapy on adults attending a UK cystic fibrosis clinic

Journal of Cystic Fibrosis

Volumn 12, Issue 1, 2013, Pages 49-53

  Fleet, J E ^a   Guha, K ^a   Piper, S ^a   Banya, W ^a   Bilton, D ^a   Hodson, M E ^a,b  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Azithromycin; Cystic fibrosis; Lung function

Indexed keywords

AZITHROMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; SPUTUM ANALYSIS; UNITED KINGDOM;

ADULT; AMBULATORY CARE FACILITIES; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; GREAT BRITAIN; HUMANS; LUNG; MAINTENANCE CHEMOTHERAPY; MALE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84870767752     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2012.05.010     Document Type: Article

References (12)

1. Murry D.J., Oermann C.M., Ou C.N., Rognerud C., Seilheimer D.K., Sockrider M.M. Pharmacokinetics of ibuprofen in patients with cystic fibrosis. Pharmacotherapy 1999, 19(3):340-345.
2. Nagai H., Shishido H., Yoneda R., Yamaguchi E., Tamura A., Kurashima A. Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis. Respiration 1991, 58(3-4):145-149.
3. Kucers A., Crowe S., Grayson M.L., Hoy J. Azithromycin. The use of antibiotics 1997, 653-662. Butterworth-Heinemann. A. Kucers, S. Crowe, M.L. Grayson, J. Hoy (Eds.).
4. Jaffe A., Francis J., Rosenthal M., Bush A. Long-term azithromycin may improve lung function in children with cystic fibrosis. Lancet 1998, 351(9100):420.
5. Wolter J., Seeney S., Bell S., Bowler S., Masel P., McCormack J. Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial. Thorax 2002, 57(3):212-216.
6. Equi A., Balfour-Lynn I.M., Bush A., Rosenthal M. Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial. Lancet 2002, 360(9338):978-984.
7. Saiman L., Marshall B.C., Mayer-Hamblett N., Burns J.L., Quittner A.L., Cibene D.A., et al. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA: The Journal of the American Medical Association 2003, 290(13):1749-1756.
8. Southern K.W., Baker P.M., Solis-Moya A. Patel. Macrolide antibiotics for cystic fibrosis. Cochrane Database of Systematic Reviews 2011, (12):CD002203.
9. Clement A., Tamalet A., Leroux E., Ravilly S., Fauroux B., Jais J.P. Long term effects of azithromycin in patients with cystic fibrosis: a double blind, placebo controlled trial. Thorax 2006, 61(10):895-902.
10. Saiman L., Anstead M., Mayer-Hamblett N., Lands L.C., Kloster M., Hocevar-Ttnka J., et al. Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA: The Journal of the American Medical Association 2010, 303(17):1707-1715.
11. Tramper-Stranders G.A., Wolfs T.F., Fleer A., Kimpen J.L., van der Ent C.K. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function. The Pediatric Infectious Disease Journal 2007, 26(1):8-12.
12. Saiman L., Mayer-Hamblett N., Campbell P., Marshall B.C. Heterogeneity of treatment response to azithromycin in patients with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine 2005, 172:1008-1012.